Literature DB >> 16479024

The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.

Elly Wijaya Nursyam1, Zulkifli Amin, C Martin Rumende.   

Abstract

AIM: to compare the vitamin D group of pulmonary tuberculosis patients with a placebo group in terms of clinical improvement, nutritional status, sputum conversion, and radiological improvement.
METHODS: sixty seven tuberculosis patient visiting the Pulmonary Clinic, of Cipto Mangunkusumo Hospital, Jakarta, from January 1st to August 31st, 2001 were included in this study. The subjects were randomised to receive vitamin D (0.25 mg/day) or placebo in a double blind method, during the 6th initial week of Tb treatment. The rate of sputum conversion, complete blood counts, blood chemistry as well as radiologic examination were evaluated.
RESULTS: there were more male patients than females (39:28), 78.7% were in the productive age group, 71.6% had low nutritional status, 62.4% with low education level, and 67.2% with low income. One hundred percent of the vitamin D group and only 76.7% of the placebo group had sputum conversion. This difference is statistically significant (p=0.002).
CONCLUSION: the sputum conversion had no correlation with the hemoglobin level, blood clotting time, calcium level, lymphocyte count, age, sex, and nutritional status. There were more subjects with radiological improvement in the vitamin D group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479024

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  102 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection.

Authors:  Beda Muehleisen; Daniel D Bikle; Carlos Aguilera; Douglas W Burton; George L Sen; Leonard J Deftos; Richard L Gallo
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

3.  Effects of sunlight and diet on vitamin D status of pulmonary tuberculosis patients in Tbilisi, Georgia.

Authors:  Nirali S Desai; Nestani Tukvadze; Jennifer K Frediani; Maia Kipiani; Ekaterine Sanikidze; Memorie M Nichols; Gautam Hebbar; Russell R Kempker; Veriko Mirtskhulava; Iagor Kalandadze; Shabnam Seydafkan; Nilay Sutaria; Tai C Chen; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha
Journal:  Nutrition       Date:  2012-02-02       Impact factor: 4.008

4.  Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis.

Authors:  D Nansera; F M Graziano; D J Friedman; M K Bobbs; A N Jones; K E Hansen
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

Review 5.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 6.  Nutritional supplements for people being treated for active tuberculosis.

Authors:  Liesl Grobler; Sukrti Nagpal; Thambu D Sudarsanam; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2016-06-29

Review 7.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

8.  Vitamin d-directed rheostatic regulation of monocyte antibacterial responses.

Authors:  John S Adams; Songyang Ren; Philip T Liu; Rene F Chun; Venu Lagishetty; Adrian F Gombart; Niels Borregaard; Robert L Modlin; Martin Hewison
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 9.  The noncalciotropic actions of vitamin D: recent clinical developments.

Authors:  Naim M Maalouf
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

Review 10.  Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

Authors:  Rene F Chun; Nancy Q Liu; T Lee; Joan I Schall; Michelle R Denburg; Richard M Rutstein; John S Adams; Babette S Zemel; Virginia A Stallings; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-08-01       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.